Randomized trial of paclitaxel- versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents: the ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) stud
about
Is There Any Significant Difference in Stent Thrombosis Between Sirolimus and Paclitaxel Eluting Stents?: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsUnderstanding and managing in-stent restenosis: a review of clinical data, from pathogenesis to treatmentHigh-throughput screening identifies idarubicin as a preferential inhibitor of smooth muscle versus endothelial cell proliferationBioresorbable vascular scaffold for coronary in-stent restenosis: a novel conceptSwitching types of drug-eluting stents does not prevent repeated in-stent restenosis in patients with coronary drug-eluting stent restenosisIdentification and characterization of [6]-shogaol from ginger as inhibitor of vascular smooth muscle cell proliferation.Comparison of bare-metal stents and drug-eluting stents in coronary ostial lesions (from the National Heart, Lung, and Blood Institute Dynamic Registry).Drug-coated balloons for the treatment of in-stent restenosis in diabetic patients: A review of currently available scientific data.Drug-coated balloons in treatment of in-stent restenosis: a meta-analysis of randomised controlled trials.Restenosis after PCI. Part 2: prevention and therapy.Surface modification of implanted cardiovascular metal stents: from antithrombosis and antirestenosis to endothelialization.Drug-coated balloons for treatment of coronary artery disease: updated recommendations from a consensus group.In-stent restenosis of drug-eluting stents.Drug-coated balloons in interventional cardiology.Drug-coated balloon angioplasty for drug-eluting stent restenosis: insight from randomized controlled trials.Angiographic patterns of drug-eluting stent restenosis after treatment with drug-coated balloon versus balloon angioplasty: Late lumen loss subgroup analyses of the PEPCAD-DES study.A novel drug-coated scoring balloon for the treatment of coronary in-stent restenosis: Results from the multi-center randomized controlled PATENT-C first in human trial.Management of drug eluting stent in-stent restenosis: A systematic review and meta-analysis.Treatment of coronary artery in-stent restenosis.Choice of stent and outcomes after treatment of drug-eluting stent restenosis in highly complex lesions.Treatment of drug-eluting stent restenosis: Comparison between drug-eluting balloon versus second-generation drug-eluting stents from a retrospective observational study.Resistant in-stent restenosis in the drug eluting stent era.Comparison between drug-coated balloon angioplasty and second-generation drug-eluting stent placement for the treatment of in-stent restenosis after drug-eluting stent implantation.Mid-Term Follow-Up of Drug-Eluting Stenting for In-Stent Restenosis: Bare-Metal Stents versus Drug-Eluting Stents.Treatment of coronary in-stent restenosis-evidence for universal recommendation?Application of response surface methodology in development of sirolimus liposomes prepared by thin film hydration techniqueDifferences in tissue characterization of restenotic neointima between sirolimus-eluting stent and bare-metal stent: integrated backscatter intravascular ultrasound analysis for in-stent restenosis.Cost-effectiveness of paclitaxel-coated balloon angioplasty in patients with drug-eluting stent restenosis.Kissing drug eluting balloons for in-stent restenosis complicating bifurcations treated with drug-eluting stents.Late catch-up phenomenon associated with stent fracture after sirolimus-eluting stent implantation: incidence and outcome.Paclitaxel-eluting balloon versus everolimus-eluting stent for treatment of drug-eluting stent restenosis.In stent restenosis remains a clinically relevant problem.Long-term outcomes of drug-eluting stent therapy for in-stent restenosis versus de novo lesions.Compassionate use of a paclitaxel coated balloon in patients with refractory recurrent coronary in-stent restenosis.Incidence of definite stent thrombosis or in-stent restenosis after drug-eluting stent implantation for treatment of coronary in-stent restenosis: from Western Denmark Heart Registry.Comparative assessment of three drug eluting stents with different platforms but with the same biodegradable polymer and the drug based on quantitative coronary angiography and optical coherence tomography at 12-month follow-up.Unimolecular Micelle-Based Hybrid System for Perivascular Drug Delivery Produces Long-Term Efficacy for Neointima Attenuation in Rats.Treatment of coronary drug-eluting stent restenosis: a journey back to the future?Treatment of sirolimus-eluting stent restenosis: additional stent, balloon angioplasty, and coronary artery bypass graft.Drug Coated Balloon Is Less Effective for Treatment of DES In-Stent Restenosis Both in Native Coronary Arteries and Saphenous Vein Grafts: Results From a Bicenter Registry.
P2860
Q26769033-7FF19114-411E-49D6-AC8E-B5AD717859E1Q28073031-AE3CF669-C332-4EB3-AFDF-5C77DD9D59B3Q28540089-3865C0D2-93EA-4182-9795-5A432B86E08DQ34112644-B9C721E3-F4EE-4C16-BE10-694E2FA838BEQ34465141-AC36C9A4-12BE-4724-BACB-51F62339A88EQ36069458-C652A5F5-BFB7-4B5D-B184-06DE97827670Q36291363-531EA90F-4707-4E4A-A616-4E26EAB77B3AQ36381320-00BCEE0F-902F-4BED-A074-174DA083E6B3Q36695192-C490CC90-22D8-4C80-A0B7-002A8CC10348Q37944416-C8AD7A5C-3C71-4241-80EA-C76B13D80220Q38092061-0CD158E9-530D-4127-84AA-47FADDE9A2BAQ38132036-CEB2F79B-504B-45B9-91F0-B98D696E9B13Q38135896-7C3324E3-DD1E-49C8-AE81-B0DB68EC1555Q38153787-F0127AF4-D285-45C2-BE41-434DF2D97DB8Q38241038-706E78FB-BC41-4036-90BC-3CFF4ED9FE69Q38386314-E0B5A4A7-49BA-49DA-BB2C-4E02D1068EA9Q38404728-9325FE3D-A038-449B-95B9-8E200DB95C1EQ38650403-F89437A4-659E-4C8F-AA46-CE1EFBECB368Q38766516-BCD599EE-5B20-4DA6-845B-B32D29129101Q39628078-32406CE5-C5D7-4C59-BCB3-DA7B7B532DC0Q40534372-66B3B0F9-3AD3-44EA-8840-4A0295EA26D2Q40752196-47DB9526-1461-453A-8426-D15DB91E7CE9Q41420992-DA2B2109-FCD2-4773-904B-E5217696B7DBQ41633062-FC4676EE-C688-4A68-BA89-C794A20D71F9Q42064609-DF739979-E73C-449A-9C45-69660814FBBBQ42174724-60163B07-15D1-4A9B-B604-A282C735C34CQ43719381-5CE911A6-0B7F-40D9-83E5-FA49C71BC72FQ43725719-7994ABF7-5A54-4292-8FBF-24951BAF9D52Q43931597-90C38595-5D15-4AD9-A003-5425DD13B48FQ43937843-8E89DFE4-4C2C-406C-8625-FC348659457EQ44130145-B41B746C-A696-401C-BA6A-22F57F1FCA01Q44133967-FD18607F-C5D3-4604-BBA5-326F46604994Q45417673-D6A18AF6-D45A-4EFE-8335-01A6D52B998FQ45751067-C27ED702-ACE6-4FEA-838D-5BB5E7A8AE41Q45843175-A1CCA18B-4407-4FD3-B092-9862DD29EFA3Q47891626-E9DA518C-9387-4CA5-B63B-AC5251CD01D8Q48019511-934B4ABE-8121-44DD-BCED-A442BEFD2464Q48197566-25103395-0CCF-487D-8036-A8EC92B16168Q50496369-3DB86047-B212-4B26-A1D7-4F52BCA78B1AQ51222907-6B53AE5D-55D4-4CDB-B65F-3B5C747E1E56
P2860
Randomized trial of paclitaxel- versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents: the ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) stud
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Randomized trial of paclitaxel ...... or In-Stent Restenosis 2) stud
@en
Randomized trial of paclitaxel ...... ting stents: the ISAR-DESIRE 2
@nl
type
label
Randomized trial of paclitaxel ...... or In-Stent Restenosis 2) stud
@en
Randomized trial of paclitaxel ...... ting stents: the ISAR-DESIRE 2
@nl
prefLabel
Randomized trial of paclitaxel ...... or In-Stent Restenosis 2) stud
@en
Randomized trial of paclitaxel ...... ting stents: the ISAR-DESIRE 2
@nl
P2093
P50
P1476
Randomized trial of paclitaxel ...... or In-Stent Restenosis 2) stud
@en
P2093
ISAR-DESIRE 2 Investigators
Klaus Tiroch
Steffen Massberg
Susanne Pinieck
P304
P356
10.1016/J.JACC.2010.02.009
P407
P50
P577
2010-03-11T00:00:00Z